Coronary Calcium Scoring

    Coronary artery disease is currently the leading cause of death and disability in the United States. Doctors have identified risk factors for treating and delaying cardiac disease, and this testing has likewise become more sophisticated.

    One of these tests that doctors order and underwriters assess carefully is the coronary artery calcium score, or CAC. While it is an independent predictor of coronary artery disease, the score is combined with information from conventional cardiac risk factors to provide very useful information.

    In coronary artery disease, a fatty material called plaque narrows the coronary artery diameters and limits blood flow crossing the heart. This is the most common cause of heart disease in both women and men and leads to chest pain, heart attack, arrhythmia and, in advanced cases, heart failure. Coronary artery calcium screening is done with an electron beam CT scan which looks for coronary calcium on the cardiac vessel walls. Calcification within the arteries can be one of the earliest signs of heart disease and can precede any signs and symptoms of the disease.

    In 1990 Arthur Agatston (the same cardiologist we know from the South Beach Diet fame) and his colleagues showed that individuals with high coronary calcium scores were at 10 times the risk of developing coronary artery disease than those with lower scores. Other studies showed that individuals with coronary calcium scores above the 75th percentile for age were 11 times more likely to develop a cardiac event compared to others having scores in the lower 25th percentile, and significantly elevated scores in the 90th percentile were 23 times more likely to develop coronary artery disease.

    Testing results start with a score of zero, which is when no calcium is seen. A score of 80 or more is associated with an increased likelihood of coronary artery disease, independent of the presence or absence of any other risk factors. Risk increases with higher calcium scores, and a result of more than 400 is quite significant. That being said, scores can rise into the thousands, with 3,000 being close to the upper limit.

     Why aren’t all insurance applicants (and for that matter, all individuals) subject to a calcium scan as a routine for their health care? The scan is painless, is usually completed within 15 minutes, and involves less than 60 seconds of actual scanning time in most cases. The major reasons are the cost, the absence of a need for excess radiation, and the fact that most people can be risk stratified without such a scan. First, the test is of low value in those who are already at low risk of coronary artery disease and who don’t have significant risk factors. The Framingham Risk score, which is a combination of risk factors evaluated that include high blood pressure, age, smoking status, diabetes, obesity, cholesterol and physical activity can help define risk noninvasively. So in those at low risk of developing cardiac disease, the test is not useful.

    In those in whom cardiac risk is high, such as people who have several risk factors, have suffered a cardiac event, or have illness relatable to cardiac disease, the score adds little. Those individuals will have more conclusive testing for cardiac disease and active modification of risk factors by their doctors, whether by medication, intervention or increased lifestyle modification. So the scan isn’t additionally helpful in this situation either. For those who are close to someone who might fit into this category, it might be wise to complete some CPR training at the Vancouver C2C First Aid Aquatics Training facility or somewhere similar so they are better equipped to deal with a cardiac event.

    Scanning may be most helpful in intermediate risk cases in which doctors are deciding whether to add medication or make major modification in risk factors. Much stricter control of blood sugar, blood pressure or cholesterol may be undertaken with an intermediate risk score. Likewise, insurers make use of these scores in order to quantify risk. Those with higher scores who are not modifying risk factors aggressively or are at higher risk for future events when the score is combined with other risk factors are assessed differently regarding future risk than those whose scores are low and in whom risk factors are either minimal or treated aggressively.

    MD, FACE, FLMI, board certified internist and endocrinologist, is medical director for SBLI of Massachusetts. He has extensive brokerage and life insurance experience over 30 years with Pacific Life, MetLife Brokerage and Transamerica Occidental Life.

    Goldstone is board certified in insurance medicine and the inaugural recipient of the W. John Elder Award for Insurance Medicine Journalism Excellence. He was also honored as a fellow of the prestigious American College of Endocrinology and has written monthly for Broker World from 1991 to September, 2021.

    Goldstone can be reached by ­telephone at 949-943-2310. Emaill: drbobgoldstone@yahoo.com.